THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q2 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $62,777,000 | +50.4% | 5,956,080 | +2.4% | 0.00% | +100.0% |
| Q3 2015 | $41,746,000 | -58.9% | 5,814,377 | +3.5% | 0.00% | -71.4% |
| Q2 2015 | $101,509,000 | +18.1% | 5,617,586 | +2.7% | 0.01% | +16.7% |
| Q1 2015 | $85,975,000 | +22.6% | 5,469,151 | +10.4% | 0.01% | +20.0% |
| Q4 2014 | $70,100,000 | -15.4% | 4,954,096 | +2.2% | 0.01% | -16.7% |
| Q3 2014 | $82,868,000 | -42.0% | 4,848,862 | +1.1% | 0.01% | -45.5% |
| Q2 2014 | $142,847,000 | -1.1% | 4,796,783 | +2.8% | 0.01% | -8.3% |
| Q1 2014 | $144,430,000 | -9.7% | 4,668,041 | +4.1% | 0.01% | -14.3% |
| Q4 2013 | $159,925,000 | -5.7% | 4,485,975 | +8.1% | 0.01% | -17.6% |
| Q3 2013 | $169,646,000 | +16.8% | 4,148,833 | +10.1% | 0.02% | +13.3% |
| Q2 2013 | $145,221,000 | – | 3,769,018 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |